{"id":"https://openalex.org/W2118987724","doi":"https://doi.org/10.1111/j.1365-2265.2008.03451.x","title":"Effects of peripheral administration of synthetic human glucose\u2010dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes","display_name":"Effects of peripheral administration of synthetic human glucose\u2010dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes","alternate_titles":[],"publication_year":2009,"publication_date":"2009-07-06","ids":{"openalex":"https://openalex.org/W2118987724","doi":"https://doi.org/10.1111/j.1365-2265.2008.03451.x","mag":"2118987724","pmid":"https://pubmed.ncbi.nlm.nih.gov/19178509"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2265.2008.03451.x","doi":"https://doi.org/10.1111/j.1365-2265.2008.03451.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2265.2008.03451.x","pdf_url":null,"source":{"id":"https://openalex.org/S182143151","display_name":"Clinical Endocrinology","issn_l":"0300-0664","issn":["0300-0664","1365-2265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Endocrinology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2118987724"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065750682","display_name":"Christina Daousi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089066","display_name":"Aintree University Hospital","ror":"https://ror.org/008j59125","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799272705","https://openalex.org/I4210089066"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"C. Daousi","raw_affiliation_strings":["University Hospital Aintree, Clinical Sciences Center, Liverpool, UK. cdaousi@liverpool.ac.uk","Diabetes and Endocrinology Clinical Research Group, University Hospital Aintree, Clinical Sciences Center, Lower Lane, Liverpool L9 7AL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Aintree, Clinical Sciences Center, Liverpool, UK. cdaousi@liverpool.ac.uk","institution_ids":["https://openalex.org/I4210089066"]},{"raw_affiliation_string":"Diabetes and Endocrinology Clinical Research Group, University Hospital Aintree, Clinical Sciences Center, Lower Lane, Liverpool L9 7AL, UK","institution_ids":["https://openalex.org/I4210089066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047195042","display_name":"John P.H. Wilding","orcid":"https://orcid.org/0000-0003-2839-8404","observed_orcids":["https://orcid.org/0000-0003-2839-8404"]},"institutions":[{"id":"https://openalex.org/I4210089066","display_name":"Aintree University Hospital","ror":"https://ror.org/008j59125","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799272705","https://openalex.org/I4210089066"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. P. H. Wilding","raw_affiliation_strings":["Diabetes and Endocrinology Clinical Research Group, University Hospital Aintree, Clinical Sciences Center, Lower Lane, Liverpool L9 7AL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes and Endocrinology Clinical Research Group, University Hospital Aintree, Clinical Sciences Center, Lower Lane, Liverpool L9 7AL, UK","institution_ids":["https://openalex.org/I4210089066"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Aditya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089066","display_name":"Aintree University Hospital","ror":"https://ror.org/008j59125","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799272705","https://openalex.org/I4210089066"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Aditya","raw_affiliation_strings":["Diabetes and Endocrinology Clinical Research Group, University Hospital Aintree, Clinical Sciences Center, Lower Lane, Liverpool L9 7AL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes and Endocrinology Clinical Research Group, University Hospital Aintree, Clinical Sciences Center, Lower Lane, Liverpool L9 7AL, UK","institution_ids":["https://openalex.org/I4210089066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039630350","display_name":"Benjamin Heath Durham","orcid":"https://orcid.org/0000-0001-8090-5448","observed_orcids":["https://orcid.org/0000-0001-8090-5448"]},"institutions":[{"id":"https://openalex.org/I2802775644","display_name":"Royal Liverpool University Hospital","ror":"https://ror.org/01ycr6b80","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160","https://openalex.org/I2802775644"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"B. H. Durham","raw_affiliation_strings":["Department of Clinical Biochemistry and Metabolic Medicine, Royal Liverpool University Hospital, Prescot Street, Liverpool L69 8XP, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Biochemistry and Metabolic Medicine, Royal Liverpool University Hospital, Prescot Street, Liverpool L69 8XP, UK","institution_ids":["https://openalex.org/I2802775644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085350927","display_name":"Jacqueline Cleator","orcid":"https://orcid.org/0000-0002-0313-101X","observed_orcids":["https://orcid.org/0000-0002-0313-101X"]},"institutions":[{"id":"https://openalex.org/I4210089066","display_name":"Aintree University Hospital","ror":"https://ror.org/008j59125","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799272705","https://openalex.org/I4210089066"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Cleator","raw_affiliation_strings":["Diabetes and Endocrinology Clinical Research Group, University Hospital Aintree, Clinical Sciences Center, Lower Lane, Liverpool L9 7AL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes and Endocrinology Clinical Research Group, University Hospital Aintree, Clinical Sciences Center, Lower Lane, Liverpool L9 7AL, UK","institution_ids":["https://openalex.org/I4210089066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071097357","display_name":"Jonathan H. Pinkney","orcid":"https://orcid.org/0000-0002-8927-1266","observed_orcids":["https://orcid.org/0000-0002-8927-1266"]},"institutions":[{"id":"https://openalex.org/I2799759729","display_name":"Royal Cornwall Hospital","ror":"https://ror.org/00cfdk448","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799477489","https://openalex.org/I2799759729"]},{"id":"https://openalex.org/I4210089066","display_name":"Aintree University Hospital","ror":"https://ror.org/008j59125","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799272705","https://openalex.org/I4210089066"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. H. Pinkney","raw_affiliation_strings":["Diabetes and Endocrinology Clinical Research Group, University Hospital Aintree, Clinical Sciences Center, Lower Lane, Liverpool L9 7AL, UK","Peninsula School of Medicine and Dentistry, The Royal Cornwall Hospital, Truro, Cornwall, TR1 3LJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes and Endocrinology Clinical Research Group, University Hospital Aintree, Clinical Sciences Center, Lower Lane, Liverpool L9 7AL, UK","institution_ids":["https://openalex.org/I4210089066"]},{"raw_affiliation_string":"Peninsula School of Medicine and Dentistry, The Royal Cornwall Hospital, Truro, Cornwall, TR1 3LJ, UK","institution_ids":["https://openalex.org/I2799759729"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038647485","display_name":"Lakshminarayan R Ranganath","orcid":"https://orcid.org/0000-0002-4205-2269","observed_orcids":["https://orcid.org/0000-0002-4205-2269"]},"institutions":[{"id":"https://openalex.org/I2802775644","display_name":"Royal Liverpool University Hospital","ror":"https://ror.org/01ycr6b80","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160","https://openalex.org/I2802775644"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L. R. Ranganath","raw_affiliation_strings":["Department of Clinical Biochemistry and Metabolic Medicine, Royal Liverpool University Hospital, Prescot Street, Liverpool L69 8XP, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Biochemistry and Metabolic Medicine, Royal Liverpool University Hospital, Prescot Street, Liverpool L69 8XP, UK","institution_ids":["https://openalex.org/I2802775644"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5065750682"],"corresponding_institution_ids":["https://openalex.org/I4210089066"],"apc_list":{"value":4250,"currency":"USD","value_usd":4250},"apc_paid":null,"fwci":1.7779,"has_fulltext":false,"cited_by_count":69,"citation_normalized_percentile":{"value":0.81673972,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"71","issue":"2","first_page":"195","last_page":"201"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.9624000191688538,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.9624000191688538,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.034699998795986176,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.996999979019165},{"id":"https://openalex.org/keywords/incretin-hormones","display_name":"incretins","score":0.6909999847412109},{"id":"https://openalex.org/keywords/energy-expenditure","display_name":"energy expenditure","score":0.949999988079071},{"id":"https://openalex.org/keywords/subjective-appetite","display_name":"subjective appetite","score":0.7940000295639038},{"id":"https://openalex.org/keywords/hunger","display_name":"hunger","score":0.8309999704360962},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.8119999766349792},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9409999847412109},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.996999979019165},{"id":"https://openalex.org/keywords/energy-balance","display_name":"energy balance","score":0.9049999713897705},{"id":"https://openalex.org/keywords/food-consumption","display_name":"dietary intake","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8542293310165405},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.8402200937271118},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7678979635238647},{"id":"https://openalex.org/C75908981","wikidata":"https://www.wikidata.org/wiki/Q28578","display_name":"Appetite","level":2,"score":0.7270641922950745},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.673469603061676},{"id":"https://openalex.org/C3018667095","wikidata":"https://www.wikidata.org/wiki/Q3455903","display_name":"Glucose homeostasis","level":4,"score":0.5705769062042236},{"id":"https://openalex.org/C2776129832","wikidata":"https://www.wikidata.org/wiki/Q22677256","display_name":"Gastric inhibitory polypeptide","level":4,"score":0.5682302713394165},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.5614101886749268},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5588861703872681},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5422379374504089},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5024523735046387},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.47631582617759705},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4408079981803894},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.30497175455093384},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001066","descriptor_name":"Appetite","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D004734","descriptor_name":"Energy Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013649","descriptor_name":"Taste","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2265.2008.03451.x","doi":"https://doi.org/10.1111/j.1365-2265.2008.03451.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2265.2008.03451.x","pdf_url":null,"source":{"id":"https://openalex.org/S182143151","display_name":"Clinical Endocrinology","issn_l":"0300-0664","issn":["0300-0664","1365-2265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Endocrinology","raw_type":"journal-article"},{"id":"pmid:19178509","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19178509","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical endocrinology","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/8dbb1984-3a72-4305-859e-09e91fd09791","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/8dbb1984-3a72-4305-859e-09e91fd09791","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Daousi, C, Wilding, J P H, Aditya, S, Durham, B H, Cleator, J, Pinkney, J H & Ranganath, L R 2009, 'Effects of peripheral administration of synthetic human glucose-dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes', Clinical Endocrinology, vol. 71, no. 2, pp. 195-201. https://doi.org/10.1111/j.1365-2265.2008.03451.x","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1852436006","https://openalex.org/W1905803407","https://openalex.org/W1952505253","https://openalex.org/W1966872231","https://openalex.org/W1969932276","https://openalex.org/W1975756049","https://openalex.org/W1980130009","https://openalex.org/W1997280776","https://openalex.org/W2005334239","https://openalex.org/W2013082477","https://openalex.org/W2018356345","https://openalex.org/W2030684076","https://openalex.org/W2041533754","https://openalex.org/W2054564814","https://openalex.org/W2067710447","https://openalex.org/W2074511950","https://openalex.org/W2074956966","https://openalex.org/W2080959651","https://openalex.org/W2084142744","https://openalex.org/W2091942573","https://openalex.org/W2096716906","https://openalex.org/W2101715455","https://openalex.org/W2103121999","https://openalex.org/W2106984011","https://openalex.org/W2121827210","https://openalex.org/W2124251664","https://openalex.org/W2124831863","https://openalex.org/W2125168546","https://openalex.org/W2138912948","https://openalex.org/W2139470224","https://openalex.org/W2143612861"],"related_works":["https://openalex.org/W3000683010","https://openalex.org/W2911644854","https://openalex.org/W2065435558","https://openalex.org/W1905803407","https://openalex.org/W1975756049","https://openalex.org/W2127219902","https://openalex.org/W2084142744","https://openalex.org/W2002171441","https://openalex.org/W2005334239"],"abstract_inverted_index":{"BACKGROUND:":[0],"Apart":[1],"from":[2],"their":[3,128],"role":[4,252],"in":[5,29,68,181,192,207,230,255,258],"insulin":[6],"secretion":[7],"and":[8,17,48,71,100,115,134,154,157,178,226,235],"glucose":[9],"homeostasis,":[10],"the":[11,30,143,205,215,250],"incretin":[12],"hormones":[13],"glucagon-like":[14],"peptide-1":[15],"(GLP-1)":[16],"glucose-dependent":[18],"insulinotropic":[19],"peptide":[20],"(GIP)":[21],"exert":[22],"a":[23,76,86,119,149,168,179],"number":[24],"of":[25,32,78,88,121,137,142,241,253],"extra-pancreatic":[26],"effects":[27],"which":[28],"case":[31],"GIP":[33,84,96,164,219,254],"remain":[34],"largely":[35],"unknown.":[36],"DESIGN/PATIENTS:":[37],"Six":[38],"obese":[39],"male":[40,52],"patients":[41,193],"with":[42,95,112,186,194,238],"diet-controlled":[43],"type":[44],"2":[45,89,98],"diabetes":[46],"(T2DM)":[47],"six":[49],"healthy":[50,171,233],"lean":[51],"subjects":[53,116,146,172,234,242],"were":[54,65,117,147],"studied.":[55],"The":[56],"protocol":[57],"included":[58],"four":[59,202],"experiments":[60],"for":[61,81,103,170,214],"each":[62],"participant":[63],"that":[64,218],"carried":[66],"out":[67],"randomized":[69],"order":[70],"included:":[72],"GLP-1":[73,91],"infusion":[74,102,165,220],"at":[75,85],"rate":[77,87,126],"1":[79,93],"pmol/kg/min":[80],"4":[82,104],"h,":[83],"pmol/kg/min,":[90],"(at":[92,97],"pmol/kg/min)":[94],"pmol/kg/min),":[99],"placebo":[101],"h.":[105],"Energy":[106],"expenditure":[107],"(EE)":[108],"was":[109,160,167,204],"measured":[110],"throughout":[111],"indirect":[113],"calorimetry":[114],"given":[118],"series":[120],"visual":[122],"analogue":[123],"scales":[124],"to":[125,132,173,245],"hourly":[127],"hunger,":[129],"fullness,":[130],"urge":[131],"eat":[133],"prospective":[135],"consumption":[136],"food.":[138],"Immediately":[139],"following":[140],"termination":[141],"infusions":[144,203],"all":[145,201],"offered":[148],"free":[150],"choice":[151],"buffet":[152],"lunch":[153],"total":[155],"calorie":[156],"macronutrient":[158],"intake":[159,199],"calculated.":[161],"RESULTS:":[162],"During":[163],"there":[166],"trend":[169],"report":[174,212],"higher":[175],"hunger":[176],"scores":[177],"reduction":[180],"EE":[182,225],"only":[183],"when":[184],"compared":[185],"placebo.":[187],"These":[188],"parameters":[189],"remained":[190],"unchanged":[191],"T2DM.":[195],"Ad":[196],"libitum":[197],"energy":[198,256],"after":[200],"same":[206],"both":[208],"groups.":[209],"CONCLUSION:":[210],"We":[211],"here":[213],"first":[216],"time":[217],"may":[221],"impact":[222],"on":[223],"resting":[224],"subjective":[227],"appetite":[228],"sensations":[229],"normal":[231],"weight":[232],"further":[236],"studies":[237],"larger":[239],"numbers":[240],"are":[243],"required":[244],"help":[246],"define":[247],"more":[248],"conclusively":[249],"precise":[251],"balance":[257],"humans.":[259]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2118987724","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
